Device
Jetstream Atherectomy System
Jetstream Atherectomy System is a medical device with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
100%(4 trials)
Phase Distribution
Ph phase_4
2
50%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (50.0%)
N/A2 (50.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME II)
NCT03847233
completednot_applicable
Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME)
NCT02733653
completedphase_4
The Jetstream (JET) Post-market Registry
NCT01436435
completedphase_4
The Jetstream G3™ Calcium Study
NCT01273623
Clinical Trials (4)
Showing 4 of 4 trials
NCT03847233Not Applicable
Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME II)
NCT02733653Not Applicable
Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME)
NCT01436435Phase 4
The Jetstream (JET) Post-market Registry
NCT01273623Phase 4
The Jetstream G3™ Calcium Study
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4